Gene description for APOBEC3B |
| Gene name |
apolipoprotein B mRNA editing enzyme catalytic subunit 3B |
| Gene symbol |
APOBEC3B |
| Other names/aliases |
A3B APOBEC1L ARCD3 ARP4 DJ742C19.2 PHRBNL bK150C2.2 |
| Species |
Homo sapiens |
Experiment description of studies that identified APOBEC3B in Prostate cancer cells |
| 1
|
| Experiment ID | 843 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
28881726
|
| Organism | Homo sapiens |
| Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
| Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
| Journal name |
Oncotarget
|
| Publication year | 2016 |
| Sample | Prostate cancer cells |
| Sample name | LNCaP - in CSS - Rep 3 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
| 2
|
| Experiment ID | 847 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
28881726
|
| Organism | Homo sapiens |
| Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
| Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
| Journal name |
Oncotarget
|
| Publication year | 2016 |
| Sample | Prostate cancer cells |
| Sample name | LNCaP - in CSS with DHT treatment - Rep 3 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
| 3
|
| Experiment ID | 964 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
25844599
|
| Organism | Homo sapiens |
| Experiment description | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
| Authors | Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T. |
| Journal name |
Oncotarget
|
| Publication year | 2015 |
| Sample | Prostate cancer cells |
| Sample name | DU145 Tax-Res |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
| Flotation density | 1.13-1.18 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry Western blotting |
| EV-TRACK |
EV150027: EV-METRIC:11%, 56%
|
|
|